Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics

CRISPR Cuts
06/09/2022 35 min Episodio 38
Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics

Listen "Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics"

Descargar episodio Ver en sitio original

Episode Synopsis

In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. 

More episodes of the podcast CRISPR Cuts

Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology 31/01/2024
Mark DeWitt and Don Kohn Discuss Their ex vivo CRISPR-based Therapy to Cure Sickle Cell Anemia 20/10/2023
Dina Simkin Breaks Down Epilepsy Cell Modeling 16/05/2023
Sunil Sharma and Raffaella Soldi Talk CRISPR For Unbiased Drug Screening for Rare Pediatric Cancers 24/04/2023
Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases 20/03/2023
Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy 05/12/2022
Ayal Hendel Talks About CRISPR in Bubble Boy Disease 07/06/2022
Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial 05/05/2022
TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials 31/03/2022
Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients 15/03/2022
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA